BioXcel Therapeutics (BTAI) PT Raised to $80 at BofA Securities
BofA Securities analyst Geoff Meacham ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
